Patents by Inventor Michael Scott McClure

Michael Scott McClure has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Triphenylethylene compounds as selective estrogen receptor modulators
    Patent number: 7442833
    Abstract: Compounds of formula (I): with a variety of therapeutic uses, more particularly novel prodrugs that are particularly useful for delivering a parent compound for selective estrogen receptor modulation.
    Type: Grant
    Filed: October 4, 2004
    Date of Patent: October 28, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: John Fred Eaddy, III, Dennis Heyer, Amarjit Sab Randhawa, Vicente Samano, John Albert Ray, Subba Reddy Katamreddy, Michael Tolar Martin, Michael Scott McClure
  • Quinazoline ditosylate salt compounds
    Patent number: 7157466
    Abstract: Ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorde4rs characterized by aberrant erbB family PTK activity.
    Type: Grant
    Filed: June 28, 2001
    Date of Patent: January 2, 2007
    Assignee: SmithKline Beecham (Cork) Limited
    Inventors: Michael Scott McClure, Martin Howard Osterhout, Frank Roschangar, Mark Joseph Sacchetti
  • Quinazoline ditosylate salt compounds
    Publication number: 20030220354
    Abstract: Ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity.
    Type: Application
    Filed: March 31, 2003
    Publication date: November 27, 2003
    Inventors: Michael Scott McClure, Martin Howard Osterhout, Frank Roschangar, Mark Joseph Sacchetti